Table 2. Estimated cost and disease impact of pneumococcal vaccination with PCV10 and PCV13 in Kenyan infants born in 2010.

	Without PCV10	PCV10 Introduction	PCV13 Introduction
Pneumococcal disease episodes *
Meningitis	3,180	1,659	1,308
Sepsis	3,449	1,626	1,229
Bacteraemic pneumonia	6,221	3,602	3,027
Non-bacteraemic pneumonia	83,537	48,310	40,497
Total disease episodes	96,387	55,197	46,061
Total reduction in disease episodes	–	41,190	50,326
Pneumococcal deaths *
Meningitis	2,275	1,186	934
Sepsis	1,448	684	576
Bacteraemic pneumonia	2,612	1,513	1,270
Non-bacteraemic pneumonia	8,077	4,671	3,916
Total pneumococcal deaths	14,412	8,054	6,636
Total reduction in pneumococcal deaths	–	6,358	7,776
Pneumococcal vaccination costs (2010 US$)
Pneumococcal vaccine procurement cost	–	$13,662,205	$13,662,205
Injection equipment cost (syringes, safety boxes)	–	$360,306	$360,306
Annualized cold chain expansion costs	–	$14,758	$70,714
Total costs of vaccination	–	$14,037,268	$14,093,224

^*The number of pneumococcal deaths and episodes are non-discounted.